📢 Applications open for Gastroenterology Editor-in-Chief! Prestige, impact, and leadership await. Deadline Mar 6.
26.01.2026 14:45 — 👍 1 🔁 1 💬 0 📌 0@amergastroassn.bsky.social
Our mission is to empower clinicians and researchers to improve digestive health. Also follow @aga-gastro.bsky.social, @aga-cgh.bsky.social, @aga-cmgh.bsky.social, @aga-tige.bsky.social, @aga-ghadvances.bsky.social.
📢 Applications open for Gastroenterology Editor-in-Chief! Prestige, impact, and leadership await. Deadline Mar 6.
26.01.2026 14:45 — 👍 1 🔁 1 💬 0 📌 0APPs: Your work in equity matters. Apply or nominate today for AGA-Pfizer Beacon of Hope Awards! Applications and nominations deadline: Feb. 9. gastro.org/beaconsofhope
23.01.2026 16:15 — 👍 1 🔁 1 💬 0 📌 0
From biologics and small molecules to AI-powered diagnostics, these were the clinical research articles that captured the most attention in 2025.
🔗 gastro.org/news/top-20-...
@aga-gastro.bsky.social @aga-cgh.bsky.social @aga-tige.bsky.social @aga-ghadvances.bsky.social
Our new CPU, published in @aga-cgh.bsky.social, outlines 14 best practices, including when to pursue physiologic testing, biofeedback therapy, and careful patient selection before considering surgery.
Read more: gastro.org/news/14-best...
What was new in GI care for 2025?
Explore our latest clinical guidelines and practice updates — covering IBD, Crohn’s disease, gastroparesis, Barrett’s esophagus, and more — to support evidence-based patient care.
🔗 gastro.org/news/whats-n...
Managing ascites, volume overload, & hyponatremia in cirrhosis requires evidence-based care.
Our new CPU in aga-gastro.bsky.social offers 13 practical tips to support decision-making and outlines future research needs.
Read more: gastro.org/news/13-tips...
⏩#GLP1 #Serotonin, the body’s multitasking maestro #DGBIs💡 🎯A blueprint for developing #orally active small-molecule secretagogues capable of activating the body’s own incretin sensors & gut-brain axis👏 📢The advent of GLP-1–based therapies has reshaped modern metabolic medicine, providing unprecedented efficacy in treating diabetes and obesity. Yet, these advances rely heavily on injectable hormone mimetics #semaglutide #tirzepatide 🎯Transform EC and L cells into tunable therapeutic switches—enabling mechanism-based, physiological treatments for diabetes, obesity, and disorders of gut–brain communication‼️ 🎯Through #neuropod synapses, EECs transmit real-time information about nutrient composition to the brain—forming a crucial component of #interoception, the body’s sense of internal state 🎯A detailed map of human enteroendocrine cell function & receptor signaling—laying the foundation for oral therapies that stimulate endogenous hormone secretion🌟 ⏩Description and functional validation of human enteroendocrine cell sensors @ScienceMagazine👏 👉 https://www.science.org/doi/10.1126/science.adl1460
Dive deep into our latest #GastroDigest @aga-gastro.bsky.social 🆕🔥
🚨Turning #GutSensors into Therapeutic Switches: A #Sensorome Roadmap for Metabolic & Gut–Brain🧠Interaction Disorders‼️ @amergastroassn.bsky.social 🙌
Prof. Kara Margolis🙏😇
👉 www.gastrojournal.org/article/S001...
#DGBI #GLP1 #Serotonin
🚨 New clinical practice update 🚨
Published in @aga-gastro.bsky.social, our latest CPU highlights endoscopic resection for early #colorectalcancer.
Read more here: gastro.org/news/new-exp...
@hopkinspress.bsky.social
#GISky
🔎 In a study of over 1.8 million colonoscopies, physicians with lower polyp detection rates may also be missing cancers present at the time of colonoscopy, emphasizing the need for quality assurance. Read more at ow.ly/MAup50XFPkE
10.12.2025 17:25 — 👍 1 🔁 1 💬 0 📌 0Apply or nominate for the AGA-Pfizer Beacon of Hope Awards for Gender and Health Equity! Deadline: Feb. 9. gastro.org/beaconsofhope #HealthEquity #WomenInGI
09.12.2025 14:30 — 👍 1 🔁 1 💬 0 📌 0
Key coding changes are coming Jan 1, 2026 for neurogastroenterologists and motility specialists:
☑️ EndoFLIP™ billable in ASCs
☑️ New CPT codes for ARM & barostat
☑️ New CPT code for IB-Stim®
Read more here: gastro.org/news/motilit...
#GISky
IBD management is complex. Support your patients’ decision making by sharing the AGA IBD Drug Guide. This resource, created by IBD specialists, offers ways to filter treatment options to provide recommendations tailored to patient needs. Explore the resource: ibddrugguide.gastro.org.
06.12.2025 14:02 — 👍 3 🔁 1 💬 0 📌 0
A new review published in @aga-cgh.bsky.social underscores the need to limit corticosteroid use in IBD to less than 2️⃣ months.
Read more here: gastro.org/news/limit-c...
#GISky
#MatchDay2026 is here! Today is the culmination of years of hard work, and we’re cheering on everyone learning their results!
Tag @amergastroassn.bsky.social to share GI program matches – we can’t wait to give the #FutureOfGI a warm welcome from the #AGAGastroSquad! #FellowMatch #GIsky #GastroSky
🚨AGA New Guideline Alert🚨
@amergastroassn.bsky.social
🔗https://smplu.link/aga_CD_guidelines
▶️AGA Living Guideline: Pharmacologic Management of Moderate-to-Severe Crohn’s Disease
I’ll break down its 16 recommendations down over the next 10 tweets 🧵 👇
#AGA #GI #CD #IBD #MedTwitter
1/10
Our review "The Role of Alcohol in Pancreatic Diseases: A Comprehensive Perspective" is now published in @aga-gastro.bsky.social @amergastroassn.bsky.social 🎉
Mechanisms of alcohol-induced injury, critical cofactors, and emerging therapies! Enjoy reading it!
www.gastrojournal.org/article/S001...
This #CrohnsAndColitisAwarenessWeek, explore the AGA IBD Drug Guide: a brand-new tool with information on potential IBD treatments and more. Use it to inform care options for your patients.
Start here ➡️ ibddrugguide.gastro.org. #CCAwarenessWeek
📣 It’s #CrohnsColitisAwarenessWeek! Ready to take your IBD knowledge to the next level?
Join us at the 2026 Crohn’s & Colitis Congress
✨ Register by Dec. 9 & save up to $166
✨ Hotel deadline: Dec. 18
👉 crohnscolitiscongress.org?utm_medium=B...
#IBD #CCCongress26 #CrohnsColitisAwarenessWeek
Author @frankiscottmd.bsky.social provides a great breakdown of our new living on managing moderate-to-severe Crohn’s disease. Clear, actionable insights for clinicians and patients alike. Looking forward to the full thread of recommendations. 👇
20.11.2025 20:52 — 👍 2 🔁 0 💬 0 📌 0
@frankiscottmd.bsky.social
#GISky
Our new clinical practice guideline, published in AGA-Gastro.bsky.social, offers 16 evidence-based recommendations for treating moderate-to-severe #Crohnsdisease.
Read more here: gastro.org/news/new-aga...
@frankiscottmd.bsky.social
#GISky
🚨Our new survey - What Americans think about obesity and how we treat it - shows more than 8 in 10 Americans believe that insurance should cover obesity treatment.
Read the release ➡️ ow.ly/PWR950XuhvR
Find resources on our Obesity Resource Center ➡️ ow.ly/aeGq50XuhqT
Obesity care is evolving. Our new quality indicators define how to deliver safe, effective pharmacologic therapy for patients with obesity.
Read more here: gastro.org/news/best-pr...
@aga-gastro.bsky.social
#GISky
🎉 Congrats @frankiscottmd.bsky.social & @benclickmd.bsky.social on their updated systematic review & network meta-analysis informing the 2025
@amergastroassn.bsky.social Clinical Guidelines on the mgmt of mod-to-severe Crohn’s disease in Gastroenterology! www.gastrojournal.org/article/S001...
This study published in @AmJGastro found that cold snare usage for removing small polyps was lower than expected for U.S. endoscopists, despite being the recommended method. ow.ly/7bH550XnVlM
07.11.2025 13:02 — 👍 0 🔁 1 💬 0 📌 0
About half of patients with positive #CRC screening tests don’t complete colonoscopy follow-up.
A new expert paper in @aga-cgh.bsky.social outlines how navigation systems can close this gap and reduce mortality.
Read more: gastro.org/news/new-exp...
#GISky
Our November issue is live! Don't miss our articles on:
⭐Member spotlight
⭐Physician payment gains and gaps
⭐Clinical implications of the new liver nomenclature
⭐Perspectives on AI in #GI and endoscopy
Read now: ow.ly/ErcI50Xnf0g
Treating patients with Barrett’s esophagus (BE)? #BE less than 1 cm in length may not require regular endoscopy for monitoring – but a diagnosis can still cause worry. Share this resource to help patients understand diagnosis + treatment options. patient.gastro.org/barretts-eso...
05.11.2025 15:09 — 👍 0 🔁 0 💬 0 📌 0
📣 The newest issue of Gastro Hep Advances is here!
🔗 ow.ly/XOfA50XiuOU
We’re seeking public feedback on newly proposed quality indicators for #IBD care — designed to promote evidence-based, consistent care for #CrohnsDisease & #UlcerativeColitis patients.
🗓️ Submit your feedback by Nov. 29: gastro.org/news/open-fo...
#GISky